Navigation Links
US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
Date:2/28/2011

WASHINGTON, Feb. 28, 2011 /PRNewswire/ -- The U.S. Supreme Court today denied Novartis Pharmaceuticals Corporation's petition for certiorari, thereby refusing to disturb the liability judgment against Novartis issued by the Second Circuit in In re Novartis Wage & Hour Litigation, 611 F.3d 141 (2010). The Second Circuit held that thousands of U.S. sales representatives ("Reps") employed by Novartis are entitled to overtime pay because the Reps are not subject to either the "Outside Sales" or "Administrative" exemptions to overtime compensation under Federal, New York and California law.

In so ruling, the Second Circuit gave controlling deference to the opinion of the U.S. Secretary of Labor, who filed an amicus brief supporting the position that two exclusions to overtime pay – the Outside Sales and Administrative exemptions – did not apply to Novartis's Reps.

"The Court's denial of certiorari to Novartis is a victory for thousands of the company's Reps who labored long and hard for Novartis – often working over 70 hours a week – and yet were denied the overtime pay that is their due," said David Sanford, founding partner in Sanford Wittels & Heisler, LLP ("SWH"), the law firm representing the Novartis Reps.  "Everybody knows that justice delayed is justice denied.  We are hopeful that Novartis will do the right thing and carry out the Second Circuit's ruling by immediately instituting an overtime compensation system for its Reps and paying the Reps the overtime monies that the company has withheld for so many years."

Another SWH partner, Jeremy Heisler, pointed out that New York state recently amended its overtime laws a
'/>"/>

SOURCE Sanford Wittels & Heisler LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Supreme Court of Israel Rules in Favor of Sun Pharma
2. Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot
3. Montana Supreme Court Decision Endangers Most Vulnerable Citizens
4. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
5. Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.
6. Final Superior Court Ruling on Trade Secret Lawsuit Favors Volcano Corporation and Its Axsun Subsidiary
7. Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
8. Massachusetts Court Rules in Favor of Volcano and Against St. Jude Medical Subsidiary in Trade Secrets Case
9. Sensipar® Patents Upheld By District Court
10. U.S. District Court Rules from Bench in Lillys Favor, Confirms Validity of Alimta Patent
11. Occlutech Wins Dutch Appeal Court Ruling Against AGA Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... -- Research and Markets ( ... "Veterinary Pharmaceutical Submissions in the EU (London, ... their offering. This practical two-day course ... parts of the application for marketing authorisation for ... authorisation is sought in the European Union, including ...
(Date:9/4/2015)... 4, 2015 Hutchison China ... Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, ... proof-of-concept ("POC") trial of fruquintinib in patients with ... China .  The top-line results ... the primary efficacy endpoint of progression free survival ...
(Date:9/3/2015)... Sept. 3, 2015 With a population of ... country and therefore also its single largest potential market ... China has led all major world economies in the ... expenditures, and government health expenditures. As an in vitro ... markets of the United States, western European countries, and ...
Breaking Medicine Technology:Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13
... (OTC Bulletin Board: ACUR) (the "Company") today announced ... "Agreement"), with an,investor group comprised of Vivo Ventures ... L.P., GCE Holdings LLC and certain individual investors,(the ... Units ("Units") at a price of $1.08 per ...
... 20 Ranbaxy Pharmaceuticals Inc.,(RPI), a wholly owned ... RLL has received approval from the U.S. Food ... and,Acetaminophen Tablets USP, 7.5 mg/750 mg, 10 mg/500 ... The Office of Generic Drugs, U.S. Food and ...
Cached Medicine Technology:Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate 2Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate 3Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP 2
(Date:9/4/2015)... ... 2015 , ... Keeping mold top of mind is important when considering indoor ... can grow anywhere - on carpet, clothing, food, paper, and even in places you ... in the home is key to preventing mold growth, which if exposed to can ...
(Date:9/4/2015)... ... ... Mike Day, a former Navy SEAL who was shot 27 times during ... Kona on October 10th. , Mike is running the race to raise awareness and ... cutting-edge treatments that restore their quality of life. More than 300,000 post ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... The USC ... was ranked number 9 nationwide by Doximity. Faculty, residents and staff are honored ... great pride in the quality of our ophthalmology residency program. Our faculty places a ...
(Date:9/4/2015)... ... September 04, 2015 , ... ECC announces ... neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. The first ... feature 30 cottage or “pocket” homes. In this community, adults will live safely ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... in comparison to settlements under the Stark physician self-referral law. “Stark Law ... 17 webinar from Atlantic Information Services, Inc. (AIS), will detail which deals are ...
Breaking Medicine News(10 mins):Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2
... (CP) is lower when compared to other causes, according ... Hepatology , the official journal of the American Gastroenterological ... their disease as well as those with non-alcohol-related causes ... "One of the more remarkable observations is that in ...
... AIDS invades human immune cells and causes them ... then infect new cells. A research team led by ... Dr. Barbara Mller of Heidelberg University Hospital have now ... cell in virion release, and discovered that the enzyme ...
... FRIDAY, March 11 (HealthDay News) -- Brandon Smith started a ... which he made heat-resistant wire closed down after 100 years ... Battle Creek, Mich., opened their mom-and-pop business, Michigan Radon Agency, ... for radon. "It,s not an easy business to get ...
... regular annual physical exam, blood is usually drawn to check ... researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say a blood ... before symptoms occur -- may someday also be offered. ... Journal of Respiratory and Critical Care Medicine, the researchers ...
... women have a new health message to hear. ... need more, according to research findings from the Case ... Cleveland Clinic. That message comes from a ... therapies for osteoporosis. Leena Palomo, assistant professor ...
... Steven Reinberg HealthDay Reporter , THURSDAY, March ... hair loss or an enlarged prostate may contribute to ... Use of dutasteride (Avodart) and finasteride (Proscar and Propecia) ... libido in a review of existing studies. In ...
Cached Medicine News:Health News:Contrary to popular belief, not all cases of chronic pancreatitis are alcohol-induced 2Health News:Pushing HIV out the door: How host factors aid in the release of HIV particles 2Health News:Inspection Can Reveal Whether Radon Problem Exists 2Health News:Simple blood test detects early emphysema in smokers before symptoms appear 2Health News:Simple blood test detects early emphysema in smokers before symptoms appear 3Health News:CWRU researcher sends message to postmenopausal women: 'Increase yearly dental checkups' 2Health News:Sexual Side Effects From Propecia, Avodart May Be Irreversible 2
... For Excellent Drainage PLUS Greater Patient ... BLAKE Drains are white, radiopaque silicone drains ... a solid core center. Their other components ... extension tubing and an adapter. The drains ...
Used for percutaneous placement of laparoscopic surgical instruments. Check-Flo® valve provides a secure seal around the instruments to be introduced. Supplied sterile in peel-open packages. Inte...
Used for internal biliary drainage. Supplied sterile in peel-open packages. Intended for one-time use....
Used for common bile duct exploration. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: